19 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
and human resources, whether any other compounds are ultimately identified. We may not be able to identify new molecules with the potential for clinical … , was discovered in our labs using our technologies. Research programs to identify new compounds will require to invest substantial technical, financial and human
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
and human resources, whether any other compounds are ultimately identified. We may not be able to identify new molecules with the potential for clinical … , was discovered in our labs using our technologies. Research programs to identify new compounds will require to invest substantial technical, financial and human
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
of compounds to treat orphan diseases and potentially, non-orphan diseases. Identifying new compounds requires substantial technical, financial and human … resources, whether any other compounds are ultimately identified. We may not be able to identify new molecules with the potential for clinical
S-8
EX-4.5
CHRO
Chromocell Therapeutics Corp.
12 Apr 24
Registration of securities for employees
7:22pm
of any potential recipients of the Data by contacting his or her local human resources representative. The Recipient authorizes the recipients … human resources representative. The Recipient understands, however, that refusing or withdrawing his or her consent may affect the Recipient’s ability
S-8
EX-4.6
CHRO
Chromocell Therapeutics Corp.
12 Apr 24
Registration of securities for employees
7:22pm
case without cost, by contacting in writing the Optionee’s local human resources representative. The Optionee understands, however, that refusing … to consent or withdrawal of consent, the Optionee understands that the Optionee may contact his or her local human resources representative.
(g) Notices. Any
424B4
scoef
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
shkien lt285yiz
20 Feb 24
Prospectus supplement with pricing info
5:28pm
DRS/A
cf16vj qjvp7w0y9xw5h
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next